Maija Itala

Summary

Affiliation: University of Turku
Country: Finland

Publications

  1. ncbi request reprint Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study
    M Itala
    Haematological Departments of Turku University Hospital, Finland Rigshospitalet, Copenhagen, Denmark
    Eur J Haematol 69:129-34. 2002
  2. ncbi request reprint Excellent response of refractory life-threatening thrombotic thrombocytopenic purpura to cyclosporine treatment
    M Itala
    Department of Medicine, Turku University Central Hospital, Turku, Finland
    Clin Lab Haematol 26:65-7. 2004
  3. ncbi request reprint Reduced-intensity conditioning and blood stem cell transplantation from an HLA-identical sibling for severe aplastic anaemia: two patients with successful engraftment but a fatal post-transplant lymphoproliferative disorder in the other
    Maija Itala
    Department of Medicine, Turku University Central Hospital, PL 52, Turku, 20521 Finland
    Hematol J 5:440-3. 2004
  4. doi request reprint Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR
    Maija Itala
    Department of Medicine, Turku University Central Hospital, Turku, Finland
    Eur J Haematol 81:100-6. 2008
  5. ncbi request reprint Autologous stem cell transplantation in patients with mantle cell lymphoma
    Riikka Oinonen
    Department of Medicine, Helsinki University Central Hospital, Finland
    Leuk Lymphoma 43:1229-37. 2002
  6. ncbi request reprint A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study
    Seija Grenman
    Department of Obstetrics and Gynaecology, Turku University Hospital, PL 52, 20521 Turku, Finland
    Eur J Cancer 42:2196-9. 2006
  7. ncbi request reprint Percutaneous coronary intervention with stenting in a patient with haemophilia A and an acute myocardial infarction following a single dose of desmopressin
    Raine Virtanen
    Department of Medicine, Turku University Central Hospital, FIN 20520 Turku, Finland
    Thromb Haemost 92:1154-6. 2004
  8. ncbi request reprint [Directions for allogenic stem cell transplants and how they reflect on the operation and results of the transfer center in Turku]
    Kari Remes
    TYKS n sis├Ątautien klinikka, Turku
    Duodecim 121:2085-97. 2005
  9. ncbi request reprint Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group
    Pirjo Koistinen
    Department of Medicine, Oulu University Hospital, Oulu, Finland
    Eur J Haematol 78:477-86. 2007

Detail Information

Publications9

  1. ncbi request reprint Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study
    M Itala
    Haematological Departments of Turku University Hospital, Finland Rigshospitalet, Copenhagen, Denmark
    Eur J Haematol 69:129-34. 2002
    ..Secondary objectives were defined as the tolerability and feasibility of rituximab in patients with CLL...
  2. ncbi request reprint Excellent response of refractory life-threatening thrombotic thrombocytopenic purpura to cyclosporine treatment
    M Itala
    Department of Medicine, Turku University Central Hospital, Turku, Finland
    Clin Lab Haematol 26:65-7. 2004
    ..Cyclosporine was tapered off after 6 months treatment, and the patient has stayed in remission ever since. We conclude that cyclosporine is a worthwhile treatment option in patients with refractory TTP...
  3. ncbi request reprint Reduced-intensity conditioning and blood stem cell transplantation from an HLA-identical sibling for severe aplastic anaemia: two patients with successful engraftment but a fatal post-transplant lymphoproliferative disorder in the other
    Maija Itala
    Department of Medicine, Turku University Central Hospital, PL 52, Turku, 20521 Finland
    Hematol J 5:440-3. 2004
    ....
  4. doi request reprint Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR
    Maija Itala
    Department of Medicine, Turku University Central Hospital, Turku, Finland
    Eur J Haematol 81:100-6. 2008
    ..001 and <0.003), two of them having non-myeloablative conditioning. None of the patients who became PCR-negative after allogeneic transplantation have relapsed...
  5. ncbi request reprint Autologous stem cell transplantation in patients with mantle cell lymphoma
    Riikka Oinonen
    Department of Medicine, Helsinki University Central Hospital, Finland
    Leuk Lymphoma 43:1229-37. 2002
    ..However, no plateau was seen in the EFS curve after ASCT. Whether cure Can be achieved in a proportion of patients with ASCT is currently unknown and should be studied in larger patient series with a longer follow-up...
  6. ncbi request reprint A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study
    Seija Grenman
    Department of Obstetrics and Gynaecology, Turku University Hospital, PL 52, 20521 Turku, Finland
    Eur J Cancer 42:2196-9. 2006
    ..We conclude that the HDCT regimen used was feasible, but did not result in significantly improved survival in this prematurely closed trial. A clinically important survival benefit cannot be excluded due to the small sample size...
  7. ncbi request reprint Percutaneous coronary intervention with stenting in a patient with haemophilia A and an acute myocardial infarction following a single dose of desmopressin
    Raine Virtanen
    Department of Medicine, Turku University Central Hospital, FIN 20520 Turku, Finland
    Thromb Haemost 92:1154-6. 2004
  8. ncbi request reprint [Directions for allogenic stem cell transplants and how they reflect on the operation and results of the transfer center in Turku]
    Kari Remes
    TYKS n sis├Ątautien klinikka, Turku
    Duodecim 121:2085-97. 2005
  9. ncbi request reprint Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group
    Pirjo Koistinen
    Department of Medicine, Oulu University Hospital, Oulu, Finland
    Eur J Haematol 78:477-86. 2007
    ..To investigate the long-term outcome of idarubicin- and cytarabine-based intensive chemotherapy in adult acute myeloid leukaemia (AML)...